Stay updated on Harvoni in Japanese Hepatitis C: Clinical Trial
Sign up to get notified when there's something new on the Harvoni in Japanese Hepatitis C: Clinical Trial page.

Latest updates to the Harvoni in Japanese Hepatitis C: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe clinical trial record for Gilead’s Harvoni post-marketing study in Japanese patients with chronic genotype 1 hepatitis C is now displayed, including its completed status, participant criteria, study locations, and measured outcomes.SummaryDifference56%

- Check15 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH notice announces a transition in terminology, saying that “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study content, indicating an access/server issue rather than an update to the study record.SummaryDifference12%

Stay in the know with updates to Harvoni in Japanese Hepatitis C: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Harvoni in Japanese Hepatitis C: Clinical Trial page.